Ocular Surface Disease
75
10
13
42
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.3%
1 terminated out of 75 trials
97.7%
+11.1% vs benchmark
17%
13 trials in Phase 3/4
12%
5 of 42 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 42 completed trials
Clinical Trials (75)
Twice-Daily Systane Complete Versus Four-Times-Daily Thealoz Duo for Dry Eye Disease
Impact of Prematurity on the Optic Nerve
Establishment of a Multimodal Standard Database for Inflammation-related Ophthalmopathy
The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease
The Efficacy of Intradermal Acupuncture for Ocular Surface Diseases After Intractable Facial Paralysis
Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency
This is a Single Center, Open-label Prospective Study to Evaluate the Effect of Xiidra® (Lifitegrast Ophthalmic Solution 5.0%) on Tear Film Biomarkers in Dry Eye
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Cataract Surgery
Wide Field OCTA in Ocular Diseases
Eyelid Closure in Keratometry
Effect of Four Different Diagnostic Eye Drops on Tear Film Thickness
Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Femto-Lasik Surgery
The Effects of Androgen Replacement Therapy on Tear Osmolarity and Ocular Surface Parameters in Androgen Deficiency
The Effect of Eye Care With Artificial Tears and Normal Saline on Ocular Surface Disease in Mechanically Ventilated Pediatric Patients
Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®
Effects of HFMH-EMS on Ocular Artery Circulation
Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF
Cool vs Room-temperature Artificial Tears
Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis